Similarly, both expression and activity of SphK1 were increased in sunitinib-resistant renal cell lines (97), and a gene-expression analysis of different tumor cell lines resistant to oxaliplatin, cisplatin, and docetaxel identified that drug resistance was related to SphK1 expression (98). This evidence concerns the gene SPHK1 and neoplasm.